TSRL Revenue and Competitors
Estimated Revenue & Valuation
- TSRL's estimated annual revenue is currently $5.4M per year.
- TSRL's estimated revenue per employee is $226,125
Employee Data
- TSRL has 24 Employees.
- TSRL grew their employee count by 0% last year.
TSRL's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Office/Facilities Manager at Therapeutic Systems Research Laboratory (TSRL) | Reveal Email/Phone |
3 | President & CEO | Reveal Email/Phone |
4 | Research Fellow | Reveal Email/Phone |
5 | Administrative Assistant | Reveal Email/Phone |
TSRL Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $67.1M | 267 | 6% | $10.8M | N/A |
#2 | $7.8M | 39 | 8% | N/A | N/A |
#3 | $5M | 25 | 4% | N/A | N/A |
#4 | $12.7M | 63 | -6% | N/A | N/A |
#5 | $16.5M | 82 | -4% | N/A | N/A |
#6 | $59.5M | 296 | 7% | N/A | N/A |
#7 | $96.2M | 342 | 29% | $764.2M | N/A |
#8 | $6.8M | 34 | 10% | N/A | N/A |
#9 | $5.4M | 27 | -4% | N/A | N/A |
#10 | $8.2M | 41 | 5% | N/A | N/A |
What Is TSRL?
TSRL is a drug delivery company who provides proprietary technology solutions to enable the oral delivery of therapeutic agents that are challenged by poor solubility, low intestinal permeability and/or high first-pass clearance. Our technology concepts are derived from internal research, oral delivery consulting services to biotech and pharmaceutical companies as well as business development efforts. Once preclinical or clinical proof of concept of the delivery technology has been reached, TSRL is seeking to form strategic partnerships or out-license the technology for further development and commercialization.
keywords:N/A
N/A
Total Funding
24
Number of Employees
$5.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TSRL News
TSRL, Inc. The consumption and production data are used to determine the regional segments of Herpes Zoste Drug market. The regional study includes PESTEL...
... Foamix Pharmaceuticals Ltd., GeneOne Life Science, GlaxoSmithKline Plc, Merck & Co., NAL Pharmaceuticals Ltd., ReceptoPharm, TSRL, Inc.
... Novartis AG, Bristol-Myers Squibb Company, Sanofi, Merck & Co., Inc., AstraZeneca, Abbott, Astellas Pharma Inc., NAL Pharma, TSRL, Inc,...
Other Companies in Ann Arbor
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 24 | 100% | N/A |
#2 | $2M | 24 | 9% | N/A |
#3 | $3.7M | 24 | -29% | N/A |
#4 | N/A | 24 | 85% | N/A |
#5 | $2.4M | 24 | 9% | N/A |